-
1141
Proinflammatory biomarkers and platelet aggregation activity in patients with coronary artery disease
Published 2024-01-01Get full text
Article -
1142
Syntaxin 17 Translocation Mediated Mitophagy Switching Drives Hyperglycemia‐Induced Vascular Injury
Published 2025-05-01Get full text
Article -
1143
Autophagy in inflammatory bowel disease: immunization, etiology, and therapeutic potential
Published 2025-08-01Get full text
Article -
1144
Mitigating oxidative stress toxicities of environmental pollutants by antioxidant nanoformulations
Published 2025-12-01Get full text
Article -
1145
-
1146
Induction of phospholipase A2 group 4C by HCV infection regulates lipid droplet formation
Published 2025-01-01“…The amount and size of lipid droplets were reduced in PLA2G4C-knockout cells. Inhibition of NF-κB or c-Myc activity suppressed lipid droplet formation in HCV-infected cells. …”
Get full text
Article -
1147
-
1148
-
1149
-
1150
-
1151
-
1152
Efficient strategy for alleviating neuronal apoptosis and oxidative stress damage of Alzheimer's disease through dual targeting BCL-2 gene promoter i-motif and β-amyloid
Published 2025-05-01“…In the Aβ1-42-induced cell model, B14 could maintain mitochondrial function and number, regulate intracellular reactive oxygen species (ROS) and Ca2+ metabolism disorders, and effectively reduce Aβ1-42-induced apoptosis. …”
Get full text
Article -
1153
-
1154
-
1155
-
1156
Accelerated biological ageing as a complication of cancer therapy
Published 2024-05-01Get full text
Article -
1157
-
1158
CD40-TRAF6 inhibition suppresses cardiovascular inflammation, oxidative stress and functional complications in a mouse model of arterial hypertension
Published 2025-03-01“…Therefore, we conclude that targeting CD40 directly on adipocytes, B-cells, T-cells, or CD40L on platelets is not a promising target to prevent hypertension complications.In summary, TRAF6 inhibition but not adipocyte, B-cell, or T-cell-specific CD40 or platelet-specific CD40L deficiency reduces pathophysiological vascular inflammation in hypertensive mice, suggesting TRAF6 inhibition as a potential therapeutic target in hypertensive patients.…”
Get full text
Article -
1159
The Mechanisms of Chronic Inflammation in Obesity and Potential Therapeutic Strategies: A Narrative Review
Published 2025-05-01“…Obesity, a global health concern of increasing significance, is characterized by chronic low-grade inflammation (LGCI) that significantly contributes to metabolic dysfunction. This narrative review explores the intricate pathophysiological mechanisms driving LGCI in obesity, emphasizing the role of adipose tissue, immune cell activation, and inflammatory signaling pathways. …”
Get full text
Article -
1160
Hypokalemic Paralysis Secondary to Immune Checkpoint Inhibitor Therapy
Published 2017-01-01Get full text
Article